With over 30 million individuals in the United States alone affected by 7,000 rare diseases,1 it is crucial to provide these patients with timely access to diagnosis and prompt t
Each year, a staggering 67 million individuals lose their lives.1 Heart disease account for approximately 17.9 million of these deaths,2 and cancer takes away 10 milli
The future of patient-centricity in pharmacovigilance involves a dynamic flow of data and information revolving around patients and enabling them — and their caregivers — to make insights-b
The clinical trial industry is hyper-focused on enhancing the participant experience. We’ve seen buzzwords like “patient convenience” and marketing campaigns around “patient centricity”.
